- Report
- October 2024
- 195 Pages
Global
From €3230EUR$3,545USD£2,805GBP
€3589EUR$3,939USD£3,116GBP
- Report
- April 2022
- 80 Pages
Global
From €5421EUR$5,950USD£4,707GBP
- Report
- January 2025
- 132 Pages
Global
From €866EUR$950USD£752GBP
Cardiovascular Anastomosis Devices are medical devices used to connect two blood vessels or other tubular structures in the cardiovascular system. These devices are used to bypass blocked or damaged vessels, to restore blood flow, and to repair congenital heart defects. They are also used to create a shunt between two vessels to divert blood flow. The devices are typically made of biocompatible materials such as polytetrafluoroethylene (PTFE) and Dacron.
The Cardiovascular Anastomosis Devices market is a subset of the larger Cardiovascular Devices market. It is a rapidly growing market, driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures.
Some of the major companies in the Cardiovascular Anastomosis Devices market include Medtronic, Johnson & Johnson, Boston Scientific, Terumo Corporation, and Abbott Laboratories. Show Less Read more